Brimonidine (brimonidine tartrate) NDC 0781-7177

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-7177Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-7177Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0781-7177-70	00781717770	1 BOTTLE, DROPPER in 1 CARTON (0781-7177-70) / 10 mL in 1 BOTTLE, DROPPERMarketed from Mar 4, 2024
0781-7177-75	00781717775	1 BOTTLE, DROPPER in 1 CARTON (0781-7177-75) / 5 mL in 1 BOTTLE, DROPPERMarketed from Mar 4, 2024
0781-7177-85	00781717785	1 BOTTLE, DROPPER in 1 CARTON (0781-7177-85) / 15 mL in 1 BOTTLE, DROPPERMarketed from Mar 4, 2024

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brimonidine
Generic name (nonproprietary): brimonidine tartrate
Active ingredients: Brimonidine tartrate — 1 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203172
Marketing start: Mar 4, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)
Identifiers: Product ID 0781-7177_185d0bdc-55b3-4d7d-9fc2-225345dfe28bSPL ID 185d0bdc-55b3-4d7d-9fc2-225345dfe28bSPL set ID 87c5a534-4321-46c7-9938-84dca34b6506RxCUI 861204UNII 4S9CL2DY2H
Pharmacologic class: alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400781717770 followed by a unit qualifier and the quantity

Package 00781-7177-70. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2025.

Indications (excerpt from the label)

Brimonidine tartrate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brimonidine tartrate ophthalmic solution is an alpha adrenergic agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)